Form 4 for MNOV MEDICINOVA INC
Accepted 2021-07-23 00:00:00 ET · period of report 2021-07-09 · accession 0001683168-21-003082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-23 | 2021-07-09 | MNOV | IWAKI YUICHI | Pres, CEO, Dir | M - OptEx | $2.54 | +39.6K | 966.9K | +4% | +$100.5K |
| D | 2021-07-23 | 2021-07-09 | MNOV | IWAKI YUICHI | Pres, CEO, Dir | M - OptEx | $0.00 | -39.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-09 | M | A | 39,583 | $2.54 | 966,933 | D | — | — | |
| 2 | Derivative | Employee Stock option (Right to Buy) | 2021-07-09 | M | D | 39,583 | $0.00 | 0 | D | $2.54 · — to 2021-07-12 | 39,583 Common Stock | (F2) The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested. |